<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR137">
 <mixed-citation publication-type="other">Zelira Therapeutics (2020) Zelira Therapeutics meets primary endpoints for phase (1b/2a) medicinal cannabis trial for insomnia. 
  <ext-link ext-link-type="uri" xlink:href="https://www.asx.com.au/asxpdf/20200407/pdf/44gs3s7427zrmt.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.asx.com.au/asxpdf/20200407/pdf/44gs3s7427zrmt.pdf</ext-link>. Accessed 9 Feb 2021.
 </mixed-citation>
</ref>
